Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-25 @ 9:30 PM
Study NCT ID:
NCT00274651
Status:
TERMINATED
Last Update Posted:
2015-07-28
First Post:
2006-01-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas
Sponsor:
Valerio Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-01
Start Date Type:
None
Primary Completion Date:
2009-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-10
First Submit QC Date:
None
Study First Post Date:
2006-01-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-06-30
Results First Submit QC Date:
None
Results First Post Date:
2014-10-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-12-21
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-07-07
Last Update Post Date:
2015-07-28
Last Update Post Date Type:
ESTIMATED